CNY 4.65
(-0.43%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 15.17 Million | -66.96 Million | 32.98 Million | 28.56 Million | -252.35 Million | -196.39 Million |
Net Income | -27.31 Million | 45.4 Million | 67.25 Million | 74.99 Million | 88.49 Million | 100.92 Million |
Depreciation & Amortization | 46.09 Million | 48.53 Million | 48.9 Million | 35.61 Million | 37.67 Million | 36.89 Million |
Deferred income taxes | -15.52 Million | -8.73 Million | -7.74 Million | -18.84 Million | -10.67 Million | -13.03 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -64.36 Million | -249.42 Million | -192.23 Million | -230.18 Million | -516.65 Million | -434.41 Million |
Other non-cash items | 30.44 Million | 88.51 Million | 109.05 Million | 148.14 Million | 138.12 Million | 100.19 Million |
Investing Cash Flow | 18.58 Million | -22.9 Million | -26.92 Million | -33.01 Million | -34.81 Million | -24.65 Million |
Investments in PPE | -17.83 Million | -20.52 Million | -26.98 Million | -34.67 Million | -35.29 Million | -24.71 Million |
Acquisitions | 40.33 Million | 69.99 Thousand | 4.74 Million | 122.67 Thousand | 1.67 Million | 56.22 Million |
Investment purchases | -4 Million | -2.45 Million | - | -122.67 Thousand | - | - |
Sales/Maturities of investments | - | -69.99 Thousand | - | 1.53 Million | - | - |
Other Investing Activities | 36.41 Million | 69.99 Thousand | -4.68 Million | 122.67 Thousand | -1.19 Million | 63.36 Thousand |
Financing Cash Flow | -66.03 Million | -67.72 Million | 253.2 Million | 31.82 Million | 171.08 Million | 198.18 Million |
Debt repayment | -18.92 Million | -507.73 Million | -507.92 Million | -590.5 Million | -372.5 Million | -450 Million |
Dividends payments | -5.65 Million | -9.23 Million | -12.27 Million | -14.72 Million | -31.11 Million | -32.64 Million |
Common Stock Repurchased | - | - | 16.8 Million | - | - | - |
Common Stock Issuance | - | - | -16.8 Million | - | - | 74.97 Million |
Other Financing Activities | -4.46 Million | 478.12 Million | 805.29 Million | 671.56 Million | 574.7 Million | 680.82 Million |
Accounts receivables | 38.84 Million | -347.29 Million | -588.5 Million | -330.39 Million | -647.58 Million | -448.14 Million |
Accounts payables | -81.36 Million | 106.73 Million | 405.89 Million | 116.48 Million | 142.77 Million | -73.41 Million |
Inventory | -6.32 Million | -132.11 Thousand | -1.87 Million | 2.56 Million | -1.16 Million | 100.18 Million |
Other working capital | -96.88 Million | -8.73 Million | -7.74 Million | -18.84 Million | -10.67 Million | -534.59 Million |
Cash at beginning of period | 486.68 Million | 644.28 Million | 385.02 Million | 357.64 Million | 473.73 Million | 496.59 Million |
Cash at end of period | 454.4 Million | 486.68 Million | 644.28 Million | 385.02 Million | 357.64 Million | 473.73 Million |
Capital Expenditure | -17.83 Million | -20.52 Million | -26.98 Million | -34.67 Million | -35.29 Million | -24.71 Million |
Effect of forex changes on cash | - | - | 1.10 | - | 0.25 | 0.54 |
Net cash flow / Change in cash | -32.27 Million | -157.6 Million | 259.26 Million | 27.37 Million | -116.08 Million | -22.86 Million |
Free Cash Flow | -2.66 Million | -87.49 Million | 5.99 Million | -6.11 Million | -287.64 Million | -221.11 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -18.87 Million | -27.82 Million | -31.83 Million | -27.31 Million | 25.58 Million | -40.74 Million |
Depreciation & Amortization | - | 9.55 Million | 9.55 Million | 46.09 Million | 46.09 Million | -22.89 Million |
Deferred income taxes | - | - | - | -15.52 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -64.36 Million | 32.52 Million | 168.47 Million |
Other non-cash items | -36.23 Million | -20.29 Million | -87.08 Million | 30.44 Million | 66.98 Million | -128.2 Million |
Investing Cash Flow | -321.73 Thousand | -19.69 Million | -2.21 Million | 18.58 Million | 34.32 Million | -1.12 Million |
Investments in PPE | -336.15 Thousand | -19.69 Million | -2.21 Million | -17.83 Million | -6.01 Million | -1.15 Million |
Acquisitions | -475.58 Thousand | 499 Thousand | - | 40.33 Million | 40.34 Million | 33.24 Thousand |
Investment purchases | - | - | - | -4 Million | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 14.42 Thousand | 9000.00 | - | 36.41 Million | 40.34 Million | 33.24 Thousand |
Financing Cash Flow | 12.97 Million | -92.61 Million | 74.13 Million | -66.03 Million | -23.52 Million | -127.08 Million |
Debt repayment | -19 Million | -86.8 Million | -80 Million | -18.92 Million | -7.64 Million | -142.39 Million |
Dividends payments | -6.02 Million | -6.29 Million | -5.5 Million | -5.65 Million | -5.65 Million | -12.06 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -5.53 Million | 490 Thousand | -360 Thousand | -4.46 Million | -360 Thousand | 27.37 Million |
Accounts receivables | - | - | - | 38.84 Million | 38.84 Million | 125.7 Million |
Accounts payables | - | - | - | -81.36 Million | - | - |
Inventory | - | - | - | -6.32 Million | -6.32 Million | 42.76 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 237.43 Million | 407.41 Million | 454.4 Million | 486.68 Million | 272.43 Million | 424 Million |
Cash at end of period | 194.97 Million | 237.43 Million | 407.41 Million | 454.4 Million | 454.4 Million | 272.43 Million |
Capital Expenditure | -336.15 Thousand | -19.69 Million | -2.21 Million | -17.83 Million | -6.01 Million | -1.15 Million |
Effect of forex changes on cash | - | - | - | - | - | -0.98 |
Net cash flow / Change in cash | -42.46 Million | -169.97 Million | -46.99 Million | -32.27 Million | 181.97 Million | -151.57 Million |
Free Cash Flow | -55.45 Million | -77.37 Million | -121.13 Million | -2.66 Million | 165.15 Million | -24.52 Million |
COGDF
SUMICHEM
BPG
MAPT4
ARFIN
RISE